Interim report for the first quarter 2017

May 17, 2017

The interim report for the period January-March 2017 will be released at 08:00 CET on May 17, 2017.

All interested parties are invited to participate in a web-cast telephone conference, which will include a presentation, on the same day at 10:00 CET. The event will be hosted by Wilson Therapeutics’ CEO Jonas Hansson and CFO Anders Martin-Löf, and the presentation will be held in English.

The live webcast and a recorded on-demand version including the presentation material will be accessible here: Link to webcast.

Questions can be asked in writing via the webcast or verbally via the conference call. To participate in the conference call, please call one of the following numbers:
SE: +46 8 566 426 62
UK: +44 203 008 9803
US: +1 855 831 5947

The presentation material will also be published before the conference starts and can be downloaded here: Link to presentation.